The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 12th 2024
The survey reported that approximately 65% of participants were concerned about their mental health, which is a 15% increase since 2020.
FDA Approves Semaglutide for New Indication Involving Cardiovascular Disease
March 8th 2024Semaglutide (Wegovy; Novo Nordisk) reduces the risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and either obesity or overweight when combined with the standard-of-care.
Read More